The plasticity of NK cell engagers enables them to simultaneously target additional moieties, as demonstrated by Schmohl et al., who constructed a TetraKE that binds CD16 on NK cells, EpCAM on carcinoma cells, and CD133 on cancer stem cells, while containing an IL-15 linker (1615EpCAM133) (276). Here, PROM1 is linked to cancer.